PT  - JOURNAL ARTICLE
AU  - Vaughan, Rebecca H.
AU  - Kresse, Jean-Claude
AU  - Farmer, Louise K.
AU  - Thézénas, Marie L.
AU  - Kessler, Benedikt M.
AU  - Lindeman, Jan H. N.
AU  - Sharples, Edward J
AU  - Welsh, Gavin I.
AU  - Nørregaard, Rikke
AU  - Ploeg, Rutger J.
AU  - Kaisar, Maria E.
TI  - Deceased donor kidney degradomics indicates cytoskeletal proteolytic alterations impacting post-transplant function
AID  - 10.1101/2021.06.10.21254305
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.06.10.21254305
4099  - http://medrxiv.org/content/early/2021/07/02/2021.06.10.21254305.short
4100  - http://medrxiv.org/content/early/2021/07/02/2021.06.10.21254305.full
AB  - Background In brain death, cerebral injury contributes to systemic biological dysregulation, causing significant cellular stress in donor kidneys that adversely impacts the quality of grafts. Here, we hypothesized that DBD kidneys may undergo proteolytic processes that renders grafts susceptible to post-transplant dysfunction.Material & Methods Using mass spectrometry and immunoblotting analyses, we profiled degradation patterns of cytoskeletal proteins in deceased (n=55) and living (n=10) donor kidneys.Results We found that in DBD kidneys, key podocyte cytoskeletal proteins had been proteolytically cleaved. Generated degradation profiles were not associated to donor related demographic and clinical factors but were associated to suboptimal post-transplant function. Strikingly, α-actinin -4 and Talin-1 degradation profiles were not observed in circulatory-death or living-donor kidneys. As Talin-1 is a specific proteolytic target of Calpain-1, we investigated a potential trigger of Calpain activation and Talin-1 degradation using ex-vivo precision-cut human kidney slices and in-vitro immortalised human podocytes. Notably, we found that Transforming-Growth Factor-β (TGF-β) activated Calpain-1 and proteolytically cleaved Talin-1 to generate distinct peptide fragments. These peptide fragments were of similar size and matched the degradation patterns observed in DBD kidneys. Talin-1 degradation was prevented in vitro by Calpain-1 inhibition.Conclusions Here, we provide initial evidence that DBD kidneys are susceptible to cytoskeletal protein degradation that impacts posttransplant kidney function. Subsequent studies should aim to further investigate the link between brain death and activation of proteolytic pathways exploring new therapeutic opportunities.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding Institutions: The PCKSs work was kindly supported by Danish Council of Independent Research, Grant number 6110-00231B, Hildur and Dagny Jacobsens Foundation, grant number 1295716-1 and Novo Nordisk Foundation, grant number NNF19OC0054481 received by R.N. This study was funded by NHS Blood and Transplant awarded to MEK & RJP.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Informed consent from donor families was obtained prior to sample procurement. Collection of QUOD samples and the research ethics approval was provided by QUOD (NW/18/0187). The collection of living donor samples and research ethics approval was provided by Oxford Transplant Biobank (OTB) 19/SC/0529.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD022074 and 10.6019/PXD022074. http://proteomecentral.proteomexchange.org/cgi/GetDataset?ID=PXD022074